To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
SUBJECTIVE EXPERIENCES OF ANOREXIA NERVOSA IN PATIENTS WITH HIGH VS LOW ANOREXIA NERVOSA POLYGENIC RISK
Karolinska Institutet, Solna, Sweden; University of North Carolina, Chapel Hill NC, USA.
Karolinska Institutet, Solna, Sweden.
Karolinska Institutet, Solna, Sweden.
Örebro University, School of Medical Sciences. Örebro University Hospital.ORCID iD: 0000-0002-1068-6929
Show others and affiliations
2023 (English)In: European Neuropsychopharmacology, ISSN 0924-977X, E-ISSN 1873-7862, Vol. 75, no Suppl. 1, p. S14-S14Article in journal, Meeting abstract (Other academic) Published
Abstract [en]

Recent genome-wide association studies (GWAS) suggest that genetic factors play a key role in its development and expression and that anorexia nervosa (AN) might have both psychiatric and metabolic underpinnings. One hypothesis is that those with high genetic vulnerability to AN may experience negative energy balance (NEB) (i.e., expending more energy than you consume) in a positive manner, rendering self-starvation and excessive exercise exceptionally reinforcing. This “paradoxical” response to NEB may also complicate recovery. In the Polygenic risk of Anorexia nervosa and its Clinical Expression (PACE) study, we explored differences in clinical and phenomenological/experiential phenotypes (i.e., how patients reported their experience of illness) in 10 individuals with AN who were in the top decile of AN polygenic risk (PRS) and 10 individuals with AN who were in the lowest decile in the Swedish subsample of the Anorexia Nervosa Genetics Initiative (ANGI) study. We interviewed the participants in a double-blind study design using a structured interview guide focusing on the experience of AN, including experiences of NEB (e.g., hunger, satiety, dietary restriction), the development of symptoms, as well as the reactions of others including family members and treatment providers to patients’ experiences of NEB. All interviews have been coded and the blind will be broken in May 2023 at which point group comparisons will be analyzed. This is the first study, to our knowledge, to explore experiential impact of genetic risk. Findings may aid in understanding risk, clinical course, and individual experience of AN and contribute suggestions for tailoring interventions with input from genetic risk profiles.

Place, publisher, year, edition, pages
Elsevier, 2023. Vol. 75, no Suppl. 1, p. S14-S14
National Category
Neurology Psychiatry
Identifiers
URN: urn:nbn:se:oru:diva-109909DOI: 10.1016/j.euroneuro.2023.08.034ISI: 001089437400034OAI: oai:DiVA.org:oru-109909DiVA, id: diva2:1815474
Conference
World Congress of Psychiatric Genetics (WCPG 2023), Montreal, Canada, October 10-14, 2023
Available from: 2023-11-29 Created: 2023-11-29 Last updated: 2023-11-29Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records

Lindstedt, Katarina

Search in DiVA

By author/editor
Lindstedt, Katarina
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
European Neuropsychopharmacology
NeurologyPsychiatry

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 65 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf